Dr Saad Al-Ismail
Did patients mention in the late 1980’s or early 1990’s about taking legal action and if so what did you tell them?
Para 45 e - Why did you take this approach?
When did you begin taking this approach?
Para 52 - Can he expand on “free of charge”? Does this include commercial concentrates as the sentence appears to suggest?
Para 53 - The mention of “invoices” is not compatible with the above.
Para 53 - Does he recall the use of unheated concentrates in 1985 and if so, over what timescale?
Para 67 - Why do you consider single UK donor units to be an advantage?
Para 76 - What evidence was made available to you to assert that products “would have been shown to be safe”
In what context do you believe products “would have been shown to be safe?” Eg is this in relation to viral risk or something else?
If products had not been shown to be safe in respect of viral transmission, do you believe that information should have been conveyed to you and others? / was it?
In relation to para 8c of this document (litigation) - minutes of meeting that he attended - https://drive.google.com/file/d/1fNcXuqm9RzKPh7P8XeeDvtDx6SvJ6Jr1/view?usp=sharing
Does he have any comment on “damage being done to the doctor/patient relationship”?
Was he aware of any other doctors acting as expert witnesses for the plaintiffs?
Does he know which manufacturer had been joined to the action?
Does he know which parts of the main statement of claim the defence were seeking to have struck out and why?
In relation to para 12d (chronic hepatitis) in the same document as above
Did he send samples to Dr Mortimer for HCV testing at this time?
In relation to this document, can he confirm what was in fact the case as there is conflicting information? - https://drive.google.com/file/d/1Fmc6FzDxBykks3EaZUUndJs1TrNeuV_v/view?usp=sharing